Publications

Pascetti, E., Floren, M., Fernandes, T. D. S., Anastasio, C., Doyle, L., & Gillette, J. (2025). Tetraspanin CD82 regulates transforming growth factor-β signaling in hematopoietic stem and progenitor cells. Molecular Biology of the Cell, 36(7), br19.

Bibikova, E., Parsa, S., Floren, M., Law, B., Clevenger, T., Cheung, J., … & Mortlock, A. (2025). Molecular profiling identifies CD49d and CD79b as predictive markers for acquired acalabrutinib resistance in patients with chronic lymphocytic leukemia. Hematological oncology, 43(1), e70008.

Shah, R., Wander, H., Hsueh, M., Floren, M., Liu, W., Cheung, P., … & Auclair, D. (2024). Multiplexed flow cytometry based immunophenotyping paired with functional ex vivo (MFLEX) drug profiling informs potential efficacy of therapeutic agents in acute myeloid leukemia. Cancer Research, 84(6_Supplement), 3904-3904.

Wu, X., Islam, S., Oien, D.B., Tokheim, C., Beacom, A., Aryal, N., Hsueh, M., Floren, M., Ross-Thriepland, D., Barrell, D. and McDermott, U. (2023). A Multi-Modal Analysis of Acquired Resistance to Acalabrutinib and Pirtobrutinib Provides Potential Strategies to Augment Treatment Outcome with BTKi Drugs. Blood, 142, 1452.

Pascetti, E.M., Restrepo-Cruz, S., Floren, M., Saito-Reis, C.A., Balise, V.D. and Gillette, J.M., 2021. Tetraspanin CD82 Regulates Hematopoietic Stem and Progenitor Cell Quiescence and Regeneration. Blood, 138(Supplement 1), pp.3264-3264.

Muskan Floren, Jennifer M. Gillette. 2021. “Acute myeloid leukemia: Therapy resistance and a potential role for tetraspanin membrane scaffolds”, The International Journal of Biochemistry & Cell Biology. (full paper)

Floren, M., S. Restrepo Cruz, C. M. Termini, K. D. Marjon, K. A. Lidke, and J. M. Gillette. 2020. “Tetraspanin CD82 drives acute myeloid leukemia chemoresistance by modulating protein kinase C alpha and beta1 integrin activation”, Oncogene. (full paper)

Saito-Reis, C. A., K. D. Marjon, E. M. Pascetti, M. Floren, and J. M. Gillette. 2018. “The tetraspanin CD82 regulates bone marrow homing and engraftment of hematopoietic stem and progenitor cells”, Molecular Biology of the Cell, 29: 2946-58.

O’Donnell, P., J. Shyu, J. Ferguson, K. Demartin, T. May, D. Jensen, M. Celeri, T. Rehage, L. Corona, R. Current, S. Joshi, Y. Wu, M. Floren, and S. Soviero. 2016. “A Real-time PCR Assay for the Detection of EGFR Mutations in FFPE Tissue and Plasma Samples of NSCLC Patients”, Journal of Clinical Oncology, 34: e23251-e51.

Turk-Kubo, K. A., M. Karamchandani, D. G. Capone, and J. P. Zehr. 2014. “The paradox of marine heterotrophic nitrogen fixation: abundances of heterotrophic diazotrophs do not account for nitrogen fixation rates in the Eastern Tropical South Pacific”, Environmental Microbiology, 16: 3095-114.

Oral Presentations

M.Floren, E.M. Pascetti, J.M. Gillette. “Impact of the CD82 scaffold on Acute Myeloid Leukemia chemosensitivity and niche interactions.” Biomedical Sciences Graduate Program Student Research Day. Albuquerque, NM. March 2020
M.Floren, K.D. Marjon, C.M. Termini, J.M. Gillette. “Impact of the CD82 scaffold on Acute Myeloid Leukemia/ niche interactions and chemosensitivity.” UNM Cancer Research Day. Albuquerque, NM. November 2019
M.Floren, K.D. Marjon, C.M. Termini, J.M. Gillette. “CD82 expression promotes acute myeloid leukemia chemoresistance and Relapse.” UNM STEM Research Symposium. Albuquerque, NM. March 2019
M.Floren, K.D. Marjon, C.M. Termini, J.M. Gillette. “Impact of the CD82 scaffold on Acute Myeloid Leukemia/ niche interactions and chemosensitivity.” 2018 ASCB Doorstep Meeting. San Diego, CA. December 2018.
M.Floren, K.D. Marjon, C.M. Termini, J.M. Gillette. “Impact of CD82 expression in acute myeloid leukemia chemoresistance and disease Relapse.” UNM Pathology Seminar Series. Albuquerque, NM. August 2018
M.Floren, K.D. Marjon, C.M. Termini, J.M. Gillette. “CD82 expression promotes acute myeloid leukemia chemoresistance.” UNM Cancer Research Day. Albuquerque, NM. May 2018.
M.Floren, K.D. Marjon, C.M. Termini, J.M. Gillette. “CD82 expression promotes acute myeloid leukemia * M.Floren, K.D. Marjon, C.M. Termini, J.M. Gillette. “Role of CD82 expression in acute myeloid leukemia” Spatiotemporal Modeling Center Seminar. Albuquerque, NM. December 2017.

Poster Presentations

M.Floren, E.M. Pascetti, J.M. Gillette. “The Membrane Scaffold CD82 Regulates Acute Myeloid Leukemia Dormancy and Bone Marrow Niche Interactions.” American Society of Hematology. Orlando, FL. December 2019
M.Floren, C.M. Termini, K.D. Marjon, J.M. Gillette. “CD82 expression promotes acute myeloid leukemia chemoresistance.” American Society for Cell Biology Annual Meeting. San Diego, CA. December 2018.
M.Floren, K.D. Marjon, C.M. Termini, J.M. Gillette. “ Role of CD82 expression in acute myeloid leukemia chemoresistance.” UNM Cancer Research Day. Albuquerque, NM. May 2018.
M.Floren, K.D. Marjon, C.M. Termini, J.M. Gillette. “ Role of CD82 expression in acute myeloid leukemia chemoresistance.” International Tetraspanin Scaffolding Research Conference. Tucson, Az. April 2018.
M.Floren, K.D. Marjon, C.M. Termini, J.M. Gillette. “CD82 expression promotes acute myeloid leukemia chemoresistance.” American Society for Cell Biology Annual Meeting. Philadelphia, PA. December 2017.
M.Floren, K.D. Marjon, C.M. Termini, J.M. Gillette. “CD82 expression promotes acute myeloid leukemia niche adhesion
Ganguly A., Rangaraj K., Karamchandani M., Cheng P., Virdi A. “A Novel Modified Green Approach to the Oxidation of Alcohols.” 187th Annual conference of the American Chemical Society, San Francisco, CA. March 2010